Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. The company is headquartered in Portage, Michigan and currently employs 56,000 full-time employees. The firm offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The firm also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Mr. Kevin Lobo es el Chairman of the Board de Stryker Corp, se unió a la empresa desde 2011.
¿Qué tal es el rendimiento del precio de la acción SYK?
El precio actual de SYK es de $327.58, ha aumentado un 0.01% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Stryker Corp?
Stryker Corp pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Stryker Corp?
La capitalización bursátil actual de Stryker Corp es $125.3B
¿Es Stryker Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 32 analistas han realizado calificaciones de análisis para Stryker Corp, incluyendo 11 fuerte compra, 16 compra, 10 mantener, 0 venta, y 11 fuerte venta